At Asha Therapeutics, we are leveraging our expertise in computational chemistry and neurobiology to develop novel therapeutics that enable the re-engineering and restoration of neurological function.
Our lead assets demonstrate efficacy in both human cells and murine models of neurodegenerative diseases including Parkinson’s Disease, Stroke, Alzheimer’s Disease, ALS, and Multiple System Atrophy.
Company Details
- Employees
- 11
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Asha Therapeutics Questions
Asha Therapeutics's website is https://www.ashatherapeutics.com/
Asha Therapeutics's LinkedIn profile is https://www.linkedin.com/company/asha-therapeutics
Asha Therapeutics has
11 employees.
View email and phone details for 11
employees at Asha Therapeutics.
Asha Therapeutics's industry is
Biotechnology Research
Asha Therapeutics's top competitors are
Cerevance,
Ibis Therapeutics,
Trace Neuroscience,
Inmune Bio Inc.,
Venn Therapeutics,
Vesalius Therapeutics,
Ac Immune,
Neurodex,
Neurogene Inc.,
Alpha Cognition, Inc..
Asha Therapeutics's categories are Biotechnology Research
